source
- STAT+: Treasury proposes major restrictions to U.S. investment in Chinese biotech sectorA new Treasury Department proposal would restrict U.S. investments in Chinese biotechs, but still allows licensing deals.STAT · 18d ago↗ source
- Moderna and Merck vaccine plus Keytruda cuts melanoma relapse risk by 42% in late-stage trialA late-stage adjuvant study of Moderna’s experimental melanoma vaccine, intismeran autogene, combined with Merck’s Keytruda showed a 42% reduction in the risk of relapse or death compared with Keyt…